MSGM
Motorsport Games Inc.
MSGM trails on the overall score without a compensating advantage in the available component scores.
NVDA
NVIDIA Corporation
NVDA has the edge over MSGM overall, supported by stronger valuation and stronger modeled upside.
MSGM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
MSGM's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
MSGM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 0.7x | $0.25 | -94% |
| Fair | 3.5x | $1.17 | -73% |
| Current | 13x | $4.28 | — |
| Expensive | 33x | $11.12 | +160% |
Historical ranges are pointers, not guarantees.
MSGM's PE is in its expensive range at 13x.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over MSGM in the historical PE scenario, which offers more potential upside but is not a forecast.
MSGM Forward outlook
There aren't enough analyst estimates for MSGM to show an outlook.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
MSGM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.34 | +325% |
| Q2 2026 | $0.42 | +$0.48 |
| Q1 2026 | $1.16 | +$1.17 |
| Q4 2025 | $1.43 | +$2.37 |
| Q3 2025 | $0.08 | -96% |
| Q2 2025 | -$0.06 | -111% |
| Q1 2025 | -$0.01 | +$3.32 |
| Q4 2024 | -$0.94 | +$4.14 |
MSGM's earnings per share have fallen from their peak: $0.34 over the past year, against $1.84 in late 2024.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over MSGM on earnings, with more consistent year-over-year improvement.
MSGM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.8M | +22% |
| Q2 2026 | $3.5M | +37% |
| Q1 2026 | $4M | +129% |
| Q4 2025 | $3.8M | +95% |
| Q3 2025 | $3.1M | +72% |
| Q2 2025 | $2.6M | +38% |
| Q1 2025 | $1.8M | -42% |
| Q4 2024 | $2M | +13% |
MSGM's revenue is recovering but still below its 2020 peak: $4M last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | +6.5 points |
| Q2 2026 | 18% | -58 points |
| Q1 2026 | 26% | +32 points |
| Q4 2025 | 15% | +48 points |
| Q3 2025 | 26% | +133 points |
| Q2 2025 | 76% | -34 points |
| Q1 2025 | -5.3% | +35 points |
| Q4 2024 | -34% | +122 points |
MSGM's operating margin was 32% last quarter, up 6.5 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over MSGM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over MSGM on profitability, with a higher operating margin.
MSGM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $1.6M | +433% |
| Q4 2025 | $1.7M | +$3.9M |
| Q4 2024 | -$2.1M | +$674.5K |
| Q3 2024 | $671.8K | +$1.9M |
| Q4 2023 | -$2.8M | -$193.2K |
| Q3 2023 | -$1.3M | +$3.7M |
| Q2 2023 | -$3.2M | +$3.4M |
| Q1 2023 | -$5.7M | -$8.6K |
NVDA has the stronger cash trend. Its trailing FCF is up 290% versus its history, compared with MSGM at up 157%.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA's free cash flow has been positive every quarter for six years: $127B over the past year, up 76% from the year before.
MSGM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.1% | +110K shares |
| 1 year | -1.7% | -91K shares |
| 3 years | +97% | +2.6M shares |
| 5 years | +361% | +4.2M shares |
| Available history | +216% | +3.7M shares |
MSGM has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2020 | — |
| Q3 2020 | — |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
MSGM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.0x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q3 2025 | 2.5x | Moderate |
| Q2 2025 | 22.6x | High |
| Q1 2025 | 19.3x | High |
| Q4 2020 | 8.2x | High |
| Q3 2020 | 3.7x | Elevated |
MSGM has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
MSGM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.5 | Neutral |
| Stochastic | 44.7 | Neutral |
MSGM's weekly RSI is 49 (neutral) and its Stochastic is 45 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
MSGM PE vs Technology Sector
| Metric | MSGM | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 28x | 55% below |
| PE % | 78 | 40 | 38 pts above |
MSGM has the edge over NVDA on valuation relative to its sector.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
MSGM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.74 | 9.7% below |
| 20 week MA | $4.51 | 5.1% below |
| 50 week MA | $4.10 | 4.4% above |
| 100 week MA | $3.20 | 34% above |
| 200 week MA | $3.35 | 28% above |
MSGM has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
MSGM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $300.0 | $40.3 | -87% |
| 2022 | $40.3 | $2.67 | -93% |
| 2023 | $2.67 | $3.09 | +16% |
| 2024 | $3.09 | $1.23 | -60% |
| 2025 | $1.23 | $3.16 | +157% |
| 2026 YTD | $3.16 | $4.28 | +35% |
MSGM has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.